Cargando…
Long-term instability of the intestinal microbiome is associated with metabolic liver disease, low microbiota diversity, diabetes mellitus and impaired exocrine pancreatic function
OBJECTIVE: The intestinal microbiome affects the prevalence and pathophysiology of a variety of diseases ranging from inflammation to cancer. A reduced taxonomic or functional diversity of the microbiome was often observed in association with poorer health outcomes or disease in general. Conversely,...
Autores principales: | Frost, Fabian, Kacprowski, Tim, Rühlemann, Malte, Pietzner, Maik, Bang, Corinna, Franke, Andre, Nauck, Matthias, Völker, Uwe, Völzke, Henry, Dörr, Marcus, Baumbach, Jan, Sendler, Matthias, Schulz, Christian, Mayerle, Julia, Weiss, Frank U, Homuth, Georg, Lerch, Markus M |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BMJ Publishing Group
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7873430/ https://www.ncbi.nlm.nih.gov/pubmed/33168600 http://dx.doi.org/10.1136/gutjnl-2020-322753 |
Ejemplares similares
-
Carrying asymptomatic gallstones is not associated with changes in intestinal microbiota composition and diversity but cholecystectomy with significant dysbiosis
por: Frost, Fabian, et al.
Publicado: (2021) -
Protective and aggressive bacterial subsets and metabolites modify hepatobiliary inflammation and fibrosis in a murine model of PSC
por: Awoniyi, Muyiwa, et al.
Publicado: (2023) -
Exocrine Pancreatic Function Modulates Plasma Metabolites Through
Changes in Gut Microbiota Composition
por: Pietzner, Maik, et al.
Publicado: (2021) -
Proton pump inhibitors affect the gut microbiome
por: Imhann, Floris, et al.
Publicado: (2016) -
Hepatocyte MyD88 affects bile acids, gut microbiota and metabolome contributing to regulate glucose and lipid metabolism
por: Duparc, Thibaut, et al.
Publicado: (2017)